Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.9K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

528
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
528
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

452
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
452
Angina IV: Management01:26

Angina IV: Management

496
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
496
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

1.0K
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
1.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplantation of a genetically modified porcine heart into a live human.

Nature medicine·2025
Same author

Pulmonic valve fibroelastoma-A rare incidental finding.

Radiology case reports·2024
Same author

Intraoperative Management of an Orthotopic Porcine-to-Human Cardiac Xenotransplant.

The Annals of thoracic surgery·2023
Same author

Reevaluating the Ethical Issues in Porcine-to-Human Heart Xenotransplantation.

The Hastings Center report·2022
Same author

Porcine Orthotopic Cardiac Xenotransplantation: The Role and Perspective of Anesthesiologists.

Journal of cardiothoracic and vascular anesthesia·2022
Same author

An Impacted Epidural Catheter.

Anesthesiology·2019

Related Experiment Video

Updated: May 6, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

23.8K

Patients with ischemic heart disease.

Patrick N Odonkor1, Alina M Grigore

  • 1Department of Anesthesiology, University of Maryland School of Medicine, Suite S8D12 22 South Greene Street, Baltimore, MD 21201, USA.

The Medical Clinics of North America
|November 5, 2013
PubMed
Summary

Patients with ischemic heart disease (IHD) face risks during surgery. Proper medication management and clear communication among care teams can significantly reduce perioperative cardiac events (PCEs).

Keywords:
Coronary artery diseaseCoronary stentsMyocardial ischemiaNoncardiac surgeryPerioperative cardiac risk assessmentPerioperative management of ischemic heart disease

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.0K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.1K

Related Experiment Videos

Last Updated: May 6, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

23.8K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.0K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.1K

Area of Science:

  • Cardiology
  • Anesthesiology
  • Surgical Care

Background:

  • Ischemic heart disease (IHD) arises from an imbalance between myocardial oxygen supply and demand.
  • Patients with IHD undergoing surgery are susceptible to perioperative cardiac events (PCEs).
  • Risk factors for PCEs include surgery type, patient comorbidities, and functional status.

Purpose of the Study:

  • To highlight the importance of appropriate perioperative management for patients with IHD.
  • To emphasize the role of medication management in reducing PCEs.
  • To underscore the necessity of interdisciplinary communication for optimal patient outcomes.

Main Methods:

  • Review of clinical risk factors and functional status in IHD patients undergoing surgery.
  • Analysis of the impact of dual antiplatelet therapy and beta-blocker management on outcomes.
  • Emphasis on clear communication protocols between surgical, cardiological, and anesthesiology teams.

Main Results:

  • Appropriate management of dual antiplatelet therapy and beta-blockers significantly impacts patient outcomes.
  • Risk stratification based on surgery type, clinical factors, and functional status is crucial.
  • Effective communication among healthcare providers is vital for successful perioperative care.

Conclusions:

  • Optimized perioperative management, including medication adjustments and interdisciplinary collaboration, is essential for reducing PCEs in IHD patients.
  • Proactive management strategies can mitigate risks associated with surgery for individuals with ischemic heart disease.
  • Clear communication pathways are fundamental to improving patient safety and outcomes in the perioperative period.